VLDLR and atherosclerosis: The main objective of our work was to select phages displaying peptides capable of binding to vascular markers present in human atheroma as well as validate its targeting properties using in vitro assays and a low-density lipoprotein receptor knockout (LDLr−/−) mouse model of atherosclerosis.